Paper5111740
Clinical trials with adriamycin.
Middleman E and 2 others. Cancer, 1971. Cited by 265 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Clinical trials with adriamycin. Papers, record 5111740. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5111740
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibiotics, Antineoplastic | Major topic |
| Adenocarcinoma | |
| Adolescent | |
| Adult | |
| Aged | |
| Breast Neoplasms | |
| Carcinoma, Squamous Cell | |
| Carcinoma, Transitional Cell | |
| Female | |
| Gastrointestinal Neoplasms | |
| Humans | |
| Kidney Neoplasms | |
| Leukemia | |
| Liposarcoma | |
| Male | |
| Melanoma | |
| Middle Aged | |
| Sarcoma | |
| Skin Neoplasms | |
| Testicular Neoplasms | |
| Thyroid Neoplasms |
Source PubMed
Cited by45
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 265 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,924,873 | Safety and Treatment Efficacy of Systemic, Locoregional, and Nanoparticle Encapsulated Anthracycline Chemotherapy: Insights Into Cardiotoxicity. | Arterioscler Thromb Vasc Biol | 2026 | https://conductscience.org/library/papers/41924873 | PubMed |
| 40,362,211 | Understanding the Mechanisms of Chemotherapy-Related Cardiotoxicity Employing hiPSC-Derived Cardiomyocyte Models for Drug Screening and the Identification of Genetic and Epigenetic Variants. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40362211 | PubMed |
| 39,875,555 | Anthracycline-induced cardiomyopathy: risk prediction, prevention and treatment. | Nat Rev Cardiol | 2025 | https://conductscience.org/library/papers/39875555 | PubMed |
| 38,989,148 | An update of the molecular mechanisms underlying anthracycline induced cardiotoxicity. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/38989148 | PubMed |
| 38,828,138 | Directly targeting BAX for drug discovery: Therapeutic opportunities and challenges. | Acta Pharm Sin B | 2024 | https://conductscience.org/library/papers/38828138 | PubMed |
| 38,173,817 | Anthracycline-induced cardiotoxicity: mechanisms, monitoring, and prevention. | Front Cardiovasc Med | 2023 | https://conductscience.org/library/papers/38173817 | PubMed |
| 38,047,045 | Doxorubicin Dose Deintensification in Pediatric Osteosarcoma, Is Less Better? | South Asian J Cancer | 2023 | https://conductscience.org/library/papers/38047045 | PubMed |
| 37,648,958 | Empagliflozin attenuates doxorubicin-impaired cardiac contractility by suppressing reactive oxygen species in isolated myocytes. | Mol Cell Biochem | 2024 | https://conductscience.org/library/papers/37648958 | PubMed |
| 36,979,503 | MicroRNA in the Diagnosis and Treatment of Doxorubicin-Induced Cardiotoxicity. | Biomolecules | 2023 | https://conductscience.org/library/papers/36979503 | PubMed |
| 36,465,474 | The role of conventional echocardiographic parameters on detecting subclinical anthracycline therapy related cardiac dysfunction-The SATRACD study. | Front Cardiovasc Med | 2022 | https://conductscience.org/library/papers/36465474 | PubMed |
| 35,879,430 | Exploration of the amino acid metabolic signature in anthracycline-induced cardiotoxicity using an optimized targeted metabolomics approach based on UPLC-MS/MS. | Naunyn Schmiedebergs Arch Pharmacol | 2022 | https://conductscience.org/library/papers/35879430 | PubMed |
| 35,845,064 | Can Dietary Nutrients Prevent Cancer Chemotherapy-Induced Cardiotoxicity? An Evidence Mapping of Human Studies and Animal Models. | Front Cardiovasc Med | 2022 | https://conductscience.org/library/papers/35845064 | PubMed |
| 35,796,280 | Detecting subclinical anthracycline therapy-related cardiac dysfunction in patients attending Uganda Cancer Institute. | Future Oncol | 2022 | https://conductscience.org/library/papers/35796280 | PubMed |
| 35,129,819 | Cardiac Expression of Esophageal Cancer-Related Gene-4 is Regulated by Sp1 and is a Potential Early Target of Doxorubicin-Induced Cardiotoxicity. | Cardiovasc Toxicol | 2022 | https://conductscience.org/library/papers/35129819 | PubMed |
| 34,795,719 | Rational and design of SATRACD study: detecting subclinical anthracycline therapy related cardiac dysfunction in low income country. | Afr Health Sci | 2021 | https://conductscience.org/library/papers/34795719 | PubMed |
| 33,669,040 | Consideration of Sex as a Biological Variable in the Development of Doxorubicin Myotoxicity and the Efficacy of Exercise as a Therapeutic Intervention. | Antioxidants (Basel) | 2021 | https://conductscience.org/library/papers/33669040 | PubMed |
| 33,151,075 | Chemical Architecture of Block Copolymers Differentially Abrogate Cardiotoxicity and Maintain the Anticancer Efficacy of Doxorubicin. | Mol Pharm | 2020 | https://conductscience.org/library/papers/33151075 | PubMed |
| 32,776,015 | A small-molecule allosteric inhibitor of BAX protects against doxorubicin-induced cardiomyopathy. | Nat Cancer | 2020 | https://conductscience.org/library/papers/32776015 | PubMed |
| 32,766,291 | Intramuscular Diphenhydramine Does Not Affect Acute Doxorubicin Infusion-Related Arrhythmia Number or Severity in a Prospective Crossover Study in Canine Lymphoma: A Pilot Study. | Front Vet Sci | 2020 | https://conductscience.org/library/papers/32766291 | PubMed |
| 32,628,743 | Subclinical anthracycline therapy-related cardiac Dysfunction: an ignored stage B heart failure in an African population. | Cardiovasc J Afr | 2020 | https://conductscience.org/library/papers/32628743 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/5111740
GET https://conductscience.org/api/papers/v1/5111740/cited_by?page=2